Navigation Links
Gene variants protect against relapse after treatment for hepatitis C
Date:3/13/2014

More than 100 million humans around the world are infected with hepatitis C virus. The infection gives rise to chronic liver inflammation, which may result in reduced liver function, liver cirrhosis and liver cancer. Even though anti-viral medications often efficiently eliminate the virus, the infection recurs in approximately one fifth of the patients.

Prevents incorporation in DNA

Martin Lagging and co-workers at the Sahlgrenska Academy have studied an enzyme called inosine trifosfatas (ITPase), which normally prevents the incorporation of defective building blocks into RNA and DNA.

Unexpectedly they found that the gene encoding for ITPase (ITPA) had significance for the treatment outcome in chronic hepatitis C virus infection.

Five times lower risk

Earlier studies had shown that approximately one third of all people carry variants of the ITPA gene that result in reduced ITPase activity. The research team at the Sahlgrenska Academy showed that patients with these gene variants exhibited a more than a five times lower risk of experiencing relapse after treatment.

Relapse a significant problem

The study encompassed over 300 patients and was carried out in cooperation with hepatitis researchers in several Nordic countries.

- Relapse after completed treatment is a significant problem in chronic hepatitis C, and the results may contribute to explaining why the infection recurs in many patients. Our hypothesis is that a low ITPase activity results in defective nucleotides being incorporated into the virus RNA, which makes the virus unstable, Martin Lagging said.

Important to other virus infections

According to Martin Lagging, the discovery may also have significance for other virus infections.

- A medication that interferes with the enzyme's activity could have a broad antiviral effect, but this must be further investigated in future studies.


'/>"/>

Contact: Krister Svahn
krister.svahn@sahlgrenska.gu.se
46-031-786-3869
University of Gothenburg
Source:Eurekalert

Page: 1

Related medicine news :

1. Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers
2. Noodles Box launches variants in serving size
3. Common gene variants explain 42 percent of antidepressant response
4. An international study identifies new DNA variants that increase the risk for cancer
5. Gene variants found to affect human lifespan
6. Researchers Link 25 New Gene Variants to Autism
7. More Gene Variants Linked to Heart Trouble
8. Bigger human genome pool uncovers rarer variants
9. New gene variants raise risk of neuroblastoma, influence tumor progression
10. Genetic variants, tobacco exposure and lung cancer risk
11. Magnesium may protect against hip fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on the ... team, can now be accessed at http://www.AISHealth.com . The data is free to ... Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Rock Your ... Pop & Rock Beauty Bash Tour. In addition, they have signed Lexi Noel, dubbed ... will appear in forthcoming print and overall branding opportunities for the company. , ...
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, 2015 , ... ... is all but universal, though the desire for invasive surgery to achieve this ideal ... can offer the results people crave without the high cost or lengthy recovery time, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... awarded independent educational grants in support of an interaction simulation session entitled "NOACS: ... activity is jointly provided by Medical Learning Institute Inc. and EDUmotion US LLC. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful rollout of its ... Cath Lab Accreditation in an Academic Setting, and The Importance of PVI Accreditation. , ... taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3
... SPRINGS, Fla., Jan. 31 Tigris Pharmaceuticals,Inc., a privately ... of Mr. Pedro Granadillo to its Board of Directors., ... Eli Lilly and,Company ("Lilly") until 2004 when he retired ... Policy Committee, which was comprised of its top,seven executives. ...
... ... Rebranding, COLUMBIA, S.C., Jan. ... involves the sole sponsorship for the,"One-on- One" match-up analysis to run ... remainder of the regular NCAA season., (Logo: http://www.newscom.com/cgi-bin/prnh/20080109/CLW033LOGO ...
... Guidance -, BRAINTREE, Mass., Jan. 31 Haemonetics,Corporation ... 2008 GAAP net,revenues of $135 million, up 18.6%; net ... share of $0.54, down 12.1%., Third quarter fiscal ... and 2008 and certain tax benefits in 2007, was ...
... took the B vitamin for one year before conception, study ... to help prevent birth defects, folic acid may also help ... study that included almost 40,000 women, a team of U.S. ... supplements for a year or longer before conception had a ...
... Strong International Performance and InLight ... Equipment Sales, GLENWOOD, ... and environmental radiation,monitoring, today reported record performance in its first fiscal quarter,ended ... Revenue reached a record $21.8 million on higher international revenues ...
... /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX:,DAX) (Nasdaq: DRAX ... Quarter and Year End 2007 on Thursday February 7, ... audio webcast at 10:00 a.m.,(ET) to discuss the results ... the conference call and webcast are as follows:, ...
Cached Medicine News:Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Colonial Life Goes 'One On One' With ESPN 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 3Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 4Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 5Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 6Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 7Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 8Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 9Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 10Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 11Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 12Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 13Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 14Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 15Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 16Health News:Folic Acid May Help Prevent Premature Birth 2Health News:Folic Acid May Help Prevent Premature Birth 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 2Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 4Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 5Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 6Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 7Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 2Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 3Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 4
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 ... medications, yet only half of consumers surveyed are aware ... have ever used use them, according to findings from ... a community service partnership focused on improving the health ... The online survey polled 1,000 men and women, ages ...
(Date:8/3/2015)... --  The Intellectual Property and Science business of ... intelligent information for businesses and professionals announced the ... Factbook , the biopharmaceutical industry,s leading resource of ... R&D, the analysis identifies a surge in global ... sales to reach $1.3 trillion by 2018. It ...
(Date:8/3/2015)... , Aug. 3, 2015 Discovery Laboratories, ... company focused on developing aerosolized KL4 surfactant therapies ... and webcast at 8:30 a.m. Eastern Time on Tuesday ... discuss the 2015 second quarter financial results along ... issue a press release announcing the second quarter ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2
... 11 InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical ... it has completed enrollment of a 360 patient Phase ... of PPAR gamma (SPPARM) for the treatment of Type ... high dose active comparator (45mg Actos(R)) and placebo controlled ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... 29th Annual Health Care Conference on Tuesday, March 17, ... Place in Boston, MA. A live webcast of the ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: